Emmecell: Clinical Trials

5 trials sponsored by Emmecell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Recruiting 2, Completed 1, Unknown 1
Phase 21Recruiting 1

Follow Emmecell: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
150K cells, 500K cells, Placebo - Corneal Edema, Fuchs
Phase 2RecruitingEmmecell1212026-10-012026-10-09
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
EO2002, Ripasudil - Corneal Edema, Corneal Endothelial Dystrophy
Phase 1RecruitingAsociación para Evitar la Ceguera en México122022-11-082025-12-08
Safety and Tolerability of EO2002
EO2002, Sham injection - Cataract, Endothelial Cell Loss, Corneal
Phase 1RecruitingAsociación para Evitar la Ceguera en México322022-08-302025-12-08
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
EO2002, EO2002 low dose, EO2002 mid dose - Corneal Edema, Corneal Endothelial Dysfunction
Phase 1CompletedEmmecell422021-06-222025-03-05
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
EO1404, Endothelial brushing or Descemet stripping - Corneal Edema, Fuchs Dystrophy
Phase 1UnknownValeria Sanchez-Huerta352016-05-042019-12-10

Conditions studied

Corneal Edema (4)  ·  Fuchs' Endothelial Dystrophy (4)  ·  Corneal Dystrophy, Posterior Polymorphous, 1 (3)  ·  Corneal Endothelial Cell Loss (2)  ·  Cataract (1)  ·  Corneal Endothelial Dystrophy 1 (1)  ·  Corneal endothelial dystrophy type 2 (1)

Interventions

K-115 (1)  ·  salicylhydroxamic acid (1)

Countries

Mexico (3)  ·  United States (2)

Top investigators

Valeria Sanchez Huerta, MD (2)  ·  Noelia Kunzevitzky (1)  ·  Noelia Kunzevitzky, PhD (1)  ·  Valeria Sanchez-Huerta, MD (1)